In tandem, public perceptions of these medications are evolving significantly. With celebrities crediting the new treatments ...

Men, Baby Boomers, and postgraduate degree-holders were among those most likely to say they wouldn’t choose medication over ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

WeightWatchers will begin selling compounded alternatives to certain weight-loss drugs that are experiencing shortages. Why ...

Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

Lots of people want to lose weight but they don't necessarily want to take regular injections to do it. That's the finding of ...

"Anything that affects metabolism that drastically, and these weight loss drugs do that biologically, it creates a false sense of satiety, and it's almost like doing surgery to a patient, very ...